Related Experiment Videos

Visibility of neurofibromatosis 1 and psychiatric morbidity

Pierre Wolkenstein, Jacques Zeller, Jean Revuz

Archives of Dermatology

|January 21, 2003

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Cherry Angiomas in Individuals With Neurofibromatosis Type 1.

JAMA dermatology·2026

A standardized imaging and analysis workflow for quantitative evaluation of cutaneous neurofibromas in Nf1-KO mice.

PloS one·2026

Immune landscape characterization of neurofibromas with atypical features in Neurofibromatosis1 reveals PD-1 and the Tim-3/Galectin-9 pathway as potential therapeutic targets.

Acta neuropathologica communications·2026

Disease burden and unmet needs in adults with neurofibromatosis type 1 and plexiform neurofibromas: A systematic literature review.

Neuro-oncology advances·2026

Stigmatization related to cutaneous neurofibromas in neurofibromatosis 1: development, validation and severity strata of the cNF-PUSH-D.

The British journal of dermatology·2025

Glial-to-mesenchymal transition of tumor Schwann cells drives the genetic burden in MPNSTs from neurofibromatosis type 1 mouse model.

Science advances·2025

See all related articles